NXG press release

TORONTO, ON / ACCESS Newswire / August 20, 2026 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its financial results for the second quarter ended June 30, 2026, with revenues of $5,160,582, net income of $993,095 and EBITDA of $1,208,529, representing substantial percentage increases of 20.8%, 181% and 92.5%, respectively, compared to the same period in 2025.

The second quarter of 2026 represented another very strong quarter for the Company, reflecting continued execution of its strategic objectives and the resilience of its business model. As market activity remained favourable, NexgenRx continued to expand its client relationships, enhance its technology platform, and improve operational efficiency, positioning the Company for sustained long-term growth.